SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001347178-20-000013
Filing Date
2020-05-07
Accepted
2020-05-07 07:01:11
Documents
77
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vnda331202010q.htm   iXBRL 10-Q 1110329
2 EXHIBIT 10.42 vndaex1042331202010q.htm EX-10.42 48707
3 EXHIBIT 31.1 vndaex311331202010q.htm EX-31.1 13579
4 EXHIBIT 31.2 vndaex312331202010q.htm EX-31.2 13537
5 EXHIBIT 32.1 vndaex321331202010q.htm EX-32.1 9464
  Complete submission text file 0001347178-20-000013.txt   5687057

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vnda-20200331.xsd EX-101.SCH 46965
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vnda-20200331_cal.xml EX-101.CAL 78323
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vnda-20200331_def.xml EX-101.DEF 195422
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vnda-20200331_lab.xml EX-101.LAB 570630
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vnda-20200331_pre.xml EX-101.PRE 352614
20 EXTRACTED XBRL INSTANCE DOCUMENT vnda331202010q_htm.xml XML 856376
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34186 | Film No.: 20854503
SIC: 2834 Pharmaceutical Preparations